[General recommendations for the management of glomerular diseases-2023].

Authors :: Windpessl M
Gauckler P
Zitt E
Lhotta K
Ay C
Eller K
Odler B
Neumann I
Rudnicki M
Kronbichler A
Säemann MD
Source :: Wiener klinische Wochenschrift [Wien Klin Wochenschr] 2023 Aug; Vol. 135 (Suppl 5), pp. 696-704. Date of Electronic Publication: 2023 Sep 20.
Publication Year :: 2023
Abstract: Glomerular diseases are associated with extrarenal complications, such as thromboembolism, cardiovascular events and particularly infections. A thorough knowledge of the various immunosuppressants and their associated toxicity profile is therefore of great importance. While nephrologists usually have extensive experience with calcineurin inhibitors and antimetabolites, two other compounds (rituximab, in severe cases cyclophosphamide) are used comparatively infrequently and will be discussed in more detail. Moreover, practical recommendations for the prevention of thromboembolism in states of nephrosis and for the prophylaxis of Pneumcystic jirovecii pneumonia are provided.<br /> (© 2023. The Author(s).)